Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Feb 5, 2026 (8 months ago)

vancomycin HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-019-59.

Affected NDC 71506-0019-59

Compare with the code on your package — it is the most precise check available.

Drug: Vancomycin

Recalling firm
Fresenius Kabi Compounding, LLC
NDC code
71506-019-59
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0337-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Vancomycin recalls

See all
Class II · Moderate risk

Vancomycin HCL

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5082-01 D-0442-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5085-01 D-0441-2026
Class II · Moderate risk

Vancomycin HCI

Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port

Ongoing Sterility / contamination Fagron Compounding Services NDC 71266-5083-01 D-0440-2026

Other recalls by Fresenius Kabi Compounding, LLC

All 2026 recalls